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Molecular mechanisms involved 
in the non-monotonic effect of 
bisphenol-a on ca2+ entry in mouse 
pancreatic β-cells
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Magdalena1, Laura Marroqui1, Ivan Quesada1, Jan-Ake Gustafsson3,4 & Angel Nadal  1
In regulatory toxicology, the dose-response relationship is a key element towards fulfilling safety 
assessments and satisfying regulatory authorities. Conventionally, the larger the dose, the greater the 
response, following the dogma “the dose makes the poison”. Many endocrine disrupting chemicals, 
including bisphenol-A (BPA), induce non-monotonic dose response (NMDR) relationships, which are 
unconventional and have tremendous implications in risk assessment. Although several molecular 
mechanisms have been proposed to explain NMDR relationships, they are largely undemonstrated. 
Using mouse pancreatic β-cells from wild-type and oestrogen receptor ERβ−/− mice, we found that 
exposure to increasing doses of BPA affected Ca2+ entry in an NMDR manner. Low doses decreased 
plasma membrane Ca2+ currents after downregulation of Cav2.3 ion channel expression, in a process 
involving ERβ. High doses decreased Ca2+ currents through an ERβ-mediated mechanism and 
simultaneously increased Ca2+ currents via oestrogen receptor ERα. The outcome of both molecular 
mechanisms explains the NMDR relationship between BPA and Ca2+ entry in β-cells.
Endocrine disrupting chemicals (EDCs) are defined by The Endocrine Society as “chemicals, or mixtures of 
chemicals, that interfere with any aspect of hormone action”1. Bisphenol-A (BPA) is a manmade chemical that 
forms the base component of the polycarbonate plastic used to produce epoxy resins and as a plasticizer in the 
manufacturing of other plastics such as PVC2. BPA is classified as an EDC, is found in the urine of 93% of USA 
citizens3 and has been associated with different non-communicable diseases including metabolic disorders4,5. 
It has been suggested that BPA may be involved in the aetiology of type 2 diabetes mellitus (T2DM) because it 
causes insulin resistance and disrupts pancreatic β-cell function in mice6–8. BPA acts at doses that are considered 
low9, ranging from 100 pM-1 nM in studies performed in vitro10,11 and after exposures ranging from 25 ng/kg/
day to 100 µg/kg/day in animal models12–15. These doses are within the range of human exposure and below 
those used in traditional toxicological studies16,17. Notably, industry workers manufacturing, or using, BPA have 
approximately 70 times higher BPA levels in urine compared to adults18.
BPA affects the pancreatic β-cell insulin content and secretion via oestrogen receptors ERα and ERβ actions 
outside the nucleus. ERα increases pancreatic β-cell insulin gene expression and, therefore, insulin content19, 
whereas ERβ blocks KATP channels with a subsequent rapid increase in insulin release20. It is of note that in 
the latter case, the relationship between the BPA dose and effect occurs in a monotonic dose-response (MDR) 
manner20, while in the former, this relationship occurs in a non-monotonic dose-response (NMDR)-dependent 
manner19. MDR curves present linear or nonlinear relationships whose slopes are either positive or negative. In 
contrast, NMDRs occur when the slope of the curve changes direction at some point within the range of the doses 
examined17. Exposure to EDCs usually elicits NMDR curves, a phenomenon particularly common in the case of 
BPA21. NMDR relationships obtained with EDCs have important implications for risk assessment because safety 
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at high doses does not guarantee that low doses are safe. Therefore, the concept of potency, highly used in risk 
assessment toxicology, cannot be applied, making it difficult or even impossible to establish a threshold below 
which no observable effect occurs. Despite the important implications that this phenomenon presents for the 
toxicological sciences, the molecular mechanisms underlying the NMDRs for EDCs remain poorly understood.
Pancreatic β-cells, similar to neurons and muscle fibres, are excitable cells, and therefore, they generate elec-
trical signals that couple stimuli to secretion. The electrical activity of a cell is defined as the ability to conduct, 
transmit and receive electrical signals that result from the opening and closing of specific ion-channel proteins 
in the plasma membrane. Pancreatic β-cells produce a particular pattern of electrical activity in bursts of action 
potentials in response to high extracellular glucose levels22. When extracellular glucose is low, the resting mem-
brane potential of the β-cell is maintained at approximately −70 mV by a particular type of ion channel, namely, 
ATP-sensitive K+ channels (KATP). These channels close when glucose is metabolized, depolarizing the plasma 
membrane and triggering the opening of several types of voltage-gated channels, which leads to the generation 
of action potential bursting23. As a consequence, the intracellular Ca2+ concentration ([Ca2+]i) oscillates24, gen-
erating a signal that triggers the exocytosis of insulin granules23. Based on the importance of ion channels in the 
physiology of pancreatic β-cells, it has been proposed that the defective insulin secretion that occurs in T2DM is 
the result of inadequate β-cell electrical activity in response to secretagogues25.
In the case of mouse β-cells, the depolarizing phase of the action potential involves exclusively voltage-gated 
Ca2+ channels, while the repolarizing phase implicates different types of K+ channels22. There are three subfam-
ilies of voltage-gated Ca2+ channels: (1) L-type Ca2+ channels that are inhibited by dihydropyridines (DHPs) 
that comprise the Cav1.1-4 channels; (2) the Cav2.1 or P/Q-type channels, which are sensitive to ω-agatoxin, the 
Cav2.2 or N-type channels, which are sensitive to ω-conotoxin, and the Cav2.3 or R-Type channels, which are 
sensitive to SNX482; and (3) the T-Type Ca2+ channels comprising Cav 3.1–326. In mouse β-cells, 50–60% of the 
total Ca2+ current flows through L-type Cav1.2 channels, which are key players in the insulin release process27,28. 
The remaining 40–50% of the Ca2+-current is equally divided between P/Q-type Ca2.1, N-Type Cav2.2 and 
R-type-Cav2.328. Islets from Cav2.3−/− mice show that the R-type channels are involved in the second phase of 
insulin release29.
Here, we show that exposure of pancreatic β-cells to BPA (from 100 pM to 1 µM) decreased Ca2+ entry via 
an ERβ-dependent pathway that involves the transcriptional regulation of Cav2.3 channels. Conversely, ERα 
increased Ca2+ entry only in response to higher BPA concentrations (100 nM and 1 µM) after increasing Ca2+ 
currents in a pathway involving phosphoinositide 3-kinase (PI3K). A low dose of 1 nM activated only the 
ERβ-dependent pathway, decreasing Ca2+ entry. Higher doses of BPA at 100 nM and 1 µM simultaneously acti-
vated both the ERα and ERβ-dependent pathways, which counteract each other. The combined opposing effects 
of ERα and ERβ upon Ca2+ entry mechanistically explain the NMDR relationship observed for BPA actions.
Results
BPA reduced the amplitude of the action potentials in pancreatic β-cells. To investigate the action 
of BPA on pancreatic β-cell signalling, we recorded electrical activity from isolated β-cells in culture using the 
perforated patch-clamp technique. The membrane potential of the β-cells remained stable at approximately −70 
mV in the absence of a stimulatory glucose concentration. When we added a stimulatory glucose concentration 
(11 mM), the membrane potential rapidly depolarized to a plateau at approximately −50 mV, where Ca2+ action 
potentials were generated (Fig. 1a). Using single β-cells cultured for 48 hours in the presence of either the vehicle 
or BPA, we found that BPA did not affect either the glucose-induced membrane potential plateau in the presence 
of 11 mM glucose (Fig. 1b,d) or the frequency of the action potential firing (Fig. 1b,e). However, BPA modified 
the waveform of these action potentials, reducing the amplitude (Fig. 1b,f) and increasing the duration at half the 
amplitude (Fig. 1c,g). Importantly, the area under the action potential was also reduced (Fig. 1c,h), suggesting 
a decrease in the amount of Ca2+ entering the cell during each action potential. Because the bursting pattern 
of the electrical activity in whole islets of Langerhans generates intracellular Ca2+ oscillations, we assessed the 
increase in [Ca2+]i in response to 11 mM glucose in islets cultured in the absence or presence of 1 nM BPA for 
48 hours. Isolated islet cells treated with BPA showed a diminished Ca2+ entry, manifested as a smaller first peak 
size induced by glucose (Fig. 2a,b) and a decreased area under the curve during the oscillatory phase in whole 
islets (Supplementary Fig. 1).
BPA decreased voltage-induced calcium entry in an NMDR manner. To determine whether Ca2+ 
entry was altered independently of glucose actions, we depolarized cells using a high extracellular K+ pulse in 
a non-stimulatory glucose concentration of 3 mM and in the presence of a KATP opener diazoxide (100 µM)30. 
Two concentrations of high KCl were used (20 mM and 65 mM), which produced depolarizations close to the 
threshold (EK ≈ −45 mV) or peak (EK ≈ −15 mV) of the depolarization-induced Ca2+ entry. Under these condi-
tions, BPA-treated cells showed a reduced depolarization-induced Ca2+ entry (Fig. 2c). This protocol was useful 
for two reasons. First, it indicated that Ca2+ entry through voltage-gated Ca2+ channels must be decreased (see 
later). Second, it allowed us to easily and rapidly test the effect of different BPA concentrations on Ca2+ entry. 
These experiments showed a remarkable phenomenon: the amplitude of the Ca2+ signal induced by both 20 mM 
and 65 mM extracellular K+ was reduced in an NMDR manner. Low concentrations (100 pM and 1 nM BPA) 
decreased Ca2+ entry compared to the control, whereas higher concentrations (10 nM and 100 nM BPA) had no 
effect (Fig. 2d,e).
The BPA treatment affected exocytosis and insulin release. To study the physiological consequences 
of reduced Ca2+ entry in the exocytosis of insulin granules, we measured the capacitance of the plasma membrane 
in response to depolarizing square pulses (−70 to 0 mV, 500 ms duration) using electrophysiological methods. 
Cells exposed to 1 nM BPA showed decreased exocytosis compared to the control in the presence of 5 mM glucose 
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 11770  | DOI:10.1038/s41598-017-11995-3
(Fig. 2f,g). This reduction was observed in the total exocytosis (Fig. 2f,g) and the initial release (first pulse, readily 
releasable pool) (data not shown). Similarly, BPA reduced insulin release in response to depolarizing extracel-
lular K+ at low glucose (Fig. 2h). The effect of BPA on high glucose-induced insulin secretion was the opposite: 
BPA potentiated glucose-induced insulin release and augmented the insulin content (Supplementary Fig. 1), as 
previously described6,19. These results point to dual regulation of exocytosis by BPA, which depends on the pres-
ence of stimulatory glucose concentrations. Although this was an interesting observation that deserved further 
Figure 1. Effect of BPA on the action potentials of mouse pancreatic β-cells. (a) Typical depolarization and 
action potential firing in bursts in response to a stimulatory glucose level (11 mM) from 0 mM glucose, recorded 
using the perforated-patch clamp technique at 36 °C. The resting membrane potential at 0 mM glucose and 
the plateau membrane potential from which the firing of the action potentials was initiated at 11 mM glucose 
are indicated. (b) Action potential firing during a burst at 11 mM glucose in the presence of vehicle (Control, 
black panel) or 1 nM BPA (blue panel). The dashed line indicates 0 mV. (c) Superimposed representative action 
potentials at 11 mM glucose in the control and 1 nM BPA. (d) Average action potential firing frequency at 
11 mM glucose in the control (1589 action potentials from n = 11 cells) and 1 nM BPA (1780, n = 11 cells). (e) 
Average plateau membrane potential at 11 mM glucose in control (n = 11) and 1 nM BPA (n = 11). (f) Average 
action potential amplitude at 11 mM glucose from plateau membrane potential to peak (1600 and 1780 action 
potentials in the control and 1 nM BPA, respectively; n = 11). (g) Average action potential duration at half of 
the amplitude at 11 mM glucose (1600 and 1780 action potentials in the control and 1 nM BPA, respectively; 
n = 11). (h) Average area under the action potential at 11 mM glucose (1600 and 1780 action potentials in 
the control and 1 nM BPA, respectively; n = 11). Data are represented as the mean ± s.e.m.; Student’s t-test: 
***P < 0.001.
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Figure 2. BPA inhibits Ca2+ entry, exocytosis and insulin secretion in mouse pancreatic β-cells. (a) 
Representative superimposed recordings of fura-2 Ca2+ fluorescence of isolated islet cells in response to a 
stimulatory glucose level (11 mM) in the control (black trace) and 1 nM BPA (blue trace). (b) Quantification 
of average amplitude change measured in (a). Measurements from 38 (black) and 21 (blue) cells from 2 
independent experiments. (c) Representative superimposed recordings of fura-2 Ca2+ fluorescence of isolated 
islet cells in response to 20 and 65 mM KCl in the control (black) and 1 nM BPA (blue) when 100 μM diazoxide 
was present in the bath solution. (d) Average amplitude of the intracellular Ca2+ responses elicited by 20 mM 
KCl in cells exposed to increasing doses of BPA for 48 hours (n = 139, 83, 145, 66 and 78 cells, obtained from 4 
independent experiments). The dotted line and arrows depict the non-monotonic dose-response relationship at 
the top of the histogram. (e) Same as in (d) but with 65 mM KCl (n = 139, 68, 143, 66 and 78 cells, obtained from 
4 independent experiments). (f) Representative superimposed recordings of the membrane capacitance increase 
(lower panel) in response to depolarizing voltage steps (−70 to 0 mV, 500 ms duration; upper panel) in isolated 
β-cells in control (black) and 1 nM BPA (blue) at 5 mM glucose. (g) Quantification of average increase in 
capacitance (normalized to the cell size in pF) at the 10th voltage pulse of the experiment shown in (f) (control: 
n = 20 cells; BPA: n = 21 cells; obtained from 6 independent experiments). (h) Average increase in insulin 
secretion of islets (normalized to the islet protein content in mg) induced by extracellular application of 65 mM 
KCl (n = 10–11 groups of 5 islets per condition from 8 animals). Data are represented as the mean ± s.e.m. In 
b,g,h: Student’s t-test: *P ≤ 0.05; ***P < 0.001. In d,e: One-way ANOVA followed by Dunnett’s post hoc test, 
*P ≤ 0.05; ***P < 0.001 vs. control.
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investigation, we focused our study on the mechanisms behind BPA regulation of Ca2+ entry at non-stimulatory 
glucose levels, in order to understand how the NMDR was generated.
BPA decreased R-Type Ca2+ currents in a non-monotonic manner. To study how BPA decreased 
Ca2+ entry, we recorded Ca2+ currents using the patch-clamp technique in a whole cell configuration. Figure 3a 
shows the recordings of the Ca2+ currents in response to depolarizing voltage pulses from −60 to +80 mV 
from a holding potential of −70 mV. The recordings from the cells treated with 1 nM BPA for 48 hours showed 
smaller currents than vehicle-treated cells (Fig. 3a). Currents were significantly smaller in the presence of BPA 
in response to depolarizing pulses from −30 to +30 mV (Fig. 3b), showing a maximum at approximately 0 mV, 
which was near the peak of the glucose-induced action potentials (see Fig. 1b). However, the Ca2+ currents were 
not modified in cells treated with 100 nM BPA (Fig. 3c). Therefore, as shown in Fig. 2d,e for the Ca2+ signals, BPA 
decreased the Ca2+ currents at a low dose of 1 nM but not at a high dose of 100 nM (Fig. 3d). This effect was simi-
lar when the natural hormone, 17β-oestradiol, was used instead of BPA (Supplementary Fig. 2).
To determine which Ca2+ current subtypes were affected by 1 nM BPA, we used specific blockers of L- and 
R-type Ca2+ currents and measured the resulting current in response to one 50-ms voltage pulse from −70 to 
0 mV, repeated every 10 s. Because a run-down of the Ca2+ currents in the whole-cell configuration has been 
reported31, we waited for the stabilization of the size of the current before we applied the specific blockers. When 
we used the L-type Ca2+ current blocker nifedipine (25 μM), the whole current was reduced by 50%, and it was 
unmodified by the BPA treatment (Fig. 4a,b). In addition to nifedipine, we added the R-type Ca2+ current blocker 
SNX-482 (200 nM), which further reduced the remaining whole current by 25% in the control cells (Fig. 4a,b). 
Notably, in cells exposed to BPA, SNX-482 blocked only a small amount of current, indicating that the R-type 
current was already reduced (Fig. 4a,b), presumably because of BPA exposure. SNX-482 also abolished the 
BPA-induced reduction in the Ca2+ entry measured in isolated β-cells treated with high extracellular K+ (data 
not shown). The percentage of Ca2+ current flowing through the N-P/Q-type Ca2+ channels was unaltered by 
BPA (Fig. 4b). These results strongly indicated that BPA exposure specifically reduced the R-type Ca2+ current. 
This may occur via activation of a signalling pathway that modulates the biophysical characteristics of the chan-
nel and/or after transcriptional regulation of the channel subunits. Therefore, we measured BPA effects on the 
mRNA expression of Cav2.3 (Cacna1e), the pore forming α subunit responsible for the R-type Ca2+ channel, and 
the mRNA expression of Cav1.2 (Cacna1c), the pore forming α subunit responsible for the L-type Ca2+ channel. 
Figure 3. BPA inhibits Ca2+ currents in a non-monotonic manner in mouse pancreatic β-cells. (a) 
Representative recordings of Ca2+ currents (lower panels) in response to depolarizing voltage pulses (−60 mV 
to +80 mV from a holding potential of −70 mV, 50 ms duration; upper panels) in control (left panel; black 
traces) and 1 nM BPA-treated (right panel; blue traces) isolated β-cells. (b) Average relationship between Ca2+ 
current density (J, Ca2+ currents normalized to the cell size in pF) and the voltage of the pulses in the control 
(black squares, n = 33) and 1 nM BPA-treated (blue circles, n = 33) cells. (c) The same experiment as in (a,b) 
but performed in β-cells cultured in the presence of 100 nM BPA (dark blue circles) (n = 12 cells/group). (d) 
Average normalized values of current density evoked at 0 mV obtained from the I–V relationship shown in (b) 
and (c). Data are represented as the mean ± s.e.m. Student’s t-test: *P ≤ 0.05; **P < 0.01. In (d). Mann-Whitney 
test compared to control: **P < 0.01.
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BPA at 1 nM significantly decreased Cav2.3 expression (Fig. 4d), but it had no effect on Cav1.2 (Fig. 4c). This 
experiment indicated that 48 hours of BPA treatment between 1 nM and 1 µM reduced Cav2.3 transcription to 
similar levels.
ERβ is involved in BPA regulation of the R-Type Ca2+ current and Cav2.3 transcription. BPA 
acts in β-cells via ERβ and ERα32. To evaluate the possible roles of these receptors in the regulation of the R-type 
Ca2+ current described above, we incubated β-cells with agonists of ERβ (DPN) and ERα (PPT). DPN (1 nM) 
imitated 1 nM BPA in reducing the Ca2+ currents (Fig. 5a), while 1 nM PPT had no effect (Fig. 5b). This was 
better visualized when we removed the L-Type component of the Ca2+ current using nifedipine (Fig. 5c). These 
results are summarized in Fig. 5d, in which we represent the percentage of the current density in response to a 
voltage pulse from −70 mV to 0 mV. Note how the total Ca2+ current is reduced by approximately 20% by DPN 
at 1 nM (left bars), while the residual current in the presence of nifedipine decreased by approximately 50% 
(right bars). When we tested these agonists on the depolarization-induced [Ca2+]i increase, we obtained simi-
lar results (Supplementary Fig. 3). The decrease in [Ca2+]i induced by 1 nM BPA was abolished using the ERβ 
antagonist PHTPP but was unaffected by the ERα antagonist MPP (Supplementary Fig. 3). These experiments 
strongly suggest the involvement of ERβ in the response to low BPA concentrations (1 nM). To further demon-
strate the implications of ERβ, we performed the same experiment as in Fig. 5c but used β-cells from wild-type 
and ERβ−/− mice. In the β-cells from the wild-type mice, BPA reduced the Ca2+ currents (Fig. 5e), but the BPA 
effect was absent in the cells from the ERβ−/− mice (Fig. 5f). When we measured the mRNA levels in the islets 
from the ERβ−/− mice, 1 nM BPA had no effect on Cacna1e expression. Regardless, it had a tendency to increase 
rather than decrease (Fig. 5g). The mRNA levels of Cacna1c remained unchanged (Fig. 5h). These experiments 
indicated that ERβ was involved in the regulation of Cacna1e transcription and likely involved, as a consequence, 
in decreasing the R-type Ca2+ currents.
Activation of ERα opposes ERβ actions on Ca2+ currents. The divergence between the observed 
effect of BPA on Ca2+ entry, which showed NMDR behaviour (see Fig. 2d,e), and the MDR relationship between 
BPA and Cacna1e expression (see Fig. 4d) strongly suggests the existence of another mechanism that is activated 
at high doses to explain the non-monotonicity. Because ERα is involved in important signalling processes trig-
gered by BPA in β-cells19, we performed the experiment depicted in Fig. 6a to test whether ERα is implicated in 
the regulation of Ca2+ entry. For this purpose, we incubated β-cells with the ERα antagonist MPP to block any 
possible ERα effect on the Ca2+ currents. When ERα was blocked, 100 nM BPA decreased the Ca2+ currents to 
Figure 4. BPA inhibits R-type Ca2+ currents in mouse pancreatic β-cells. (a) Representative recordings 
of the Ca2+ currents in isolated β-cells in response to a depolarizing voltage pulse (−70 to 0 mV, 50-ms 
duration) in the absence of specific blockers (whole current), in the presence of 25 μM nifedipine (L-type 
current component blocker) and in the presence of 25 μM nifedipine +200 nM SNX-482 (R-type current 
component blocker) applied sequentially to the control (left panel) and 1 nM BPA-treated (right panel) cells. 
(b) Average Ca2+ current density percentage of the different components (compared to whole Ca2+ current 
density) in control (black bars, n = 8 cells) and in the presence of 1 nM BPA (blue bars, n = 9 cells). (c) Relative 
Cav1.2 (Cacna1c) mRNA expression in the control (black bar) or 1 nM BPA-treated (blue bar) whole islets. 
Expression was normalized to the housekeeping gene Hprt1 (control, n = 8; 1 nM BPA, n = 7; obtained from 3 
independent experiments). (d) Relative Cav2.3 (Cacna1e) mRNA expression in islets exposed to 1 nM (n = 12), 
100 nM (n = 13) and 1000 nM BPA (n = 7) for 48 hours, relative to control expression (n = 35; obtained from 
12 experiments). Expression was normalized to the housekeeping gene Hprt1. Student’s t-test: *P ≤ 0.05; 
**P < 0.01.
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Figure 5. BPA-induced inhibition of R-Type Ca2+ current and Cav2.3 transcription involves oestrogen receptor 
β. (a) Average relationship between the Ca2+ current density and the voltage of the pulses in β-cells (Control; 
black squares, n = 20) or treated with 1 nM DPN for 48 hours (grey circles, n = 21). (b) The same experiment 
as in (a) but using β-cells treated with 1 nM PPT (red symbols, n = 16) for 48 hours. (c) Average relationship 
between the Ca2+ current density and the voltage of the pulses in the presence of 25 μM nifedipine. Control 
β-cells (Control; black squares, n = 6) or cells treated with 1 nM DPN (grey circles, n = 7) or 1 nM PPT (red 
circles, n = 5) for 48 hours. (d) Histogram summarizing the average normalized peak Ca2+ current density 
shown in panels (a),(b) and (c). (e) Average relationship between the Ca2+ current density and the voltage of 
the pulses in the presence of 25 μM nifedipine. Pancreatic β-cells from wild-type mice were left untreated (wt; 
black squares, n = 12) or treated with 1 nM BPA (wt + BPA; blue circles, n = 18 cells) for 48 hours. (f) The same 
experiment as in (e) but with β-cells from ERβ−/− mice (ERβ−/−; black squares, n = 11 cells; ERβ−/− + BPA; blue 
circles, n = 11 cells). (g) Relative Cav2.3 (Cacna1e) mRNA expression in whole islets from ERβ−/− mice. Islets 
were untreated (black bar) or treated with 1 nM BPA (blue bar) for 48 hours. Expression was normalized to the 
housekeeping gene Hprt1. (h) As in (g) but showing the relative mRNA expression of Cav1.2 (Cacna1c gen). 
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a similar extent as 1 nM BPA, yet 100 nM BPA in the absence of MPP had no effect (Figs 3c,d and 6a,b). This 
result suggests that ERα may counteract the ERβ reduction of Ca2+ entry by increasing the Ca2+ currents in 
response to 100 nM BPA. Note that we did not use cells from the ERα−/− mice because these mice were obese 
and insulin-resistant from an early age33, and obesity changes ion channel activity, calcium signalling and exocy-
tosis34. To further demonstrate the role of ERα on Ca2+ current potentiation we exposed cells to increasing doses 
of the ERα agonist PPT. Figure 6c,d, demonstrates that 100 nM and 1 µM PTT increased the Ca2+ currents. This 
occurred along a wide voltage range (Fig. 6c) in an MDR manner (Fig. 6d).
The potentiation of the Ca2+ currents by high doses of either PPT or BPA might be due to an effect that is 
opposite to that of ERβ on Cacna1e expression. To test this hypothesis, we measured Cacan1e mRNA in response 
to 100 nM and 1 µM PPT, but no changes were observed upon PPT exposure (Fig. 7a). Furthermore, the 100 nM 
BPA-induced decrease in the mRNA Cacan1e levels remained unchanged in the presence of the ERα blocker 
MPP (Fig. 7b). Although we cannot rule out transcriptional downregulation of other Ca2+ channel genes, this 
result points to an effect of ERα activation beyond Cacan1e expression. Therefore, ERα does not counteract the 
transcriptional effect of ERβ at high BPA concentrations.
In addition to the role of ERα in the regulation of gene expression, it is well known that ERα acts outside of the 
cell nucleus by activating PI3K and ERK1/2 signalling cascades, among others35–37. In β-cells, for instance, ERα 
activation of ERK1/2 regulates insulin biosynthesis19,38. To investigate whether these kinases play a role in the 
potentiation of Ca2+ entry, we measured the Ca2+ currents in cells incubated with PPT at 100 nM to activate ERα, 
in the presence and absence of the broad-spectrum PI3K inhibitor wortmannin (Fig. 7c–f and Supplementary 
Fig. 4). We observed that the 100 nM PPT-induced potentiation of the Ca2+ currents was abolished by wortman-
nin, while wortmannin itself had no effect on the Ca2+ currents (Fig. 7c–f and Supplementary Fig. 4).
To demonstrate that PI3K was involved in the response to 100 nM BPA, we performed the experiment shown 
in Fig. 7e. Cells incubated with the vehicle (control) or 100 nM BPA showed identical Ca2+ currents. However, 
cells incubated in the presence of 100 nM BPA plus wortmannin showed a decreased Ca2+ current. The ERK1/2 
blocker PD98059 had no effect on the potentiation of the Ca2+ currents by 100 nM PPT (Supplementary Fig. 4). 
This experiment indicates that the potentiation of the Ca2+ currents by high doses of BPA may involve PI3K.
Discussion
Non-monotonic dose response curves have been demonstrated for natural hormones and EDCs in a variety of 
biological systems39,40. However, a proper understanding of NMDRs for EDCs, including the underlying molec-
ular mechanisms, remains elusive. The findings obtained here indicate that the highly produced and ubiqui-
tous EDC, BPA, alters the shape of glucose-induced action potentials in β-cells by decreasing its amplitude and 
increasing their width. The amplitude of the action potentials in mouse β-cells depends on voltage-gated Ca2+ 
channels. Therefore, a decreased amplitude should be correlated with diminished Ca2+ entry. This was manifested 
when Ca2+ signals in response to glucose and extracellular K+ depolarization were measured in whole islets. 
Remarkably, the relationship between [Ca2+] signaling, elicited by a high extracellular K+ depolarization and 
BPA, was non-monotonic, i.e., Ca2+ signaling decreased in response to low BPA concentrations (100 pM and 
1 nM), but higher concentrations (10 and 100 nM) produced no effect (Fig. 2d,e). We should note that 1 nM BPA 
is approximately the concentration of BPA in serum of USA population9,17, while higher levels between 10 and 
100 nM may be expected in industry workers using BPA18.
As described in the introduction, this type of NMDR curve is commonly obtained in response to EDC expo-
sure, and this NMDR curve type has tremendous implications in the whole field of toxicology and particularly, in 
regulatory toxicology17,40,41. We decided, therefore, to focus on understanding the molecular mechanisms under-
lying this behaviour.
The decrease in Ca2+ signalling provoked by a low dose of BPA (1 nM) was associated with a reduction in the 
Ca2+ currents in response to depolarizing voltage pulses (Fig. 3a,b). The pharmacological dissection indicated that 
the channel that was downregulated by 1 nM BPA was Cav2.3, which is responsible of the R-type Ca2+ current and 
represents 25% of the whole Ca2+ current42 (Fig. 4a,b). The decreased of R-type Ca2+ currents after BPA exposure 
were likely a consequence of transcriptional downregulation of the Cacna1e gene, which encodes the alpha-1E 
subunit of the Cav2.3 channels (Fig. 4b). The consequences of downregulating Cacna1e expression were similar, 
although not identical, to those described in β-cells from the Cav2.3−/− mice29. In both the Cav2.3−/− mice 
and our BPA model, there was a decrease in the glucose-induced Ca2+ response in the whole islets of Langerhans. 
However, at the single β-cell level, the capacitance experiments performed here indicated that exocytosis was 
diminished from the initial component. This is slightly different from the situation found in the Cav2.3−/− mice, 
in which the later component of exocytosis was decreased while the first component was not affected much29. 
Therefore, we cannot discard other effects that are unrelated to downregulation of Cav2.3 gene expression in the 
modulation of the exocytotic pathways. Interestingly, we found that the consequences of the BPA treatment on 
insulin exocytosis and secretion were different in the absence and presence of glucose. In the absence of glucose, 
there was decreased Ca2+ entry in response to extracellular K+-induced membrane depolarization. This was likely 
responsible for the diminished exocytosis and the decreased insulin release in response to high extracellular K+ 
in BPA-treated cells. In contrast, insulin release and exocytosis in the presence of 11 mM glucose were potentiated 
by a 1-nM BPA incubation, despite the decreased glucose-induced calcium signals (Supplementary Fig. 1c–e). 
This highly suggests that BPA also regulated the exocytotic machinery independently of Ca2+ entry. Glucose 
In the measurements shown in g,h, the RNA samples were obtained from the ERβ−/− islets of 3 independent 
experiments (Control; black bars, n = 6; 1 nM BPA; blue bars, n = 6). Data are represented as the mean ± s.e.m. 
Student’s t-test: *P ≤ 0.05; **P < 0.01; ***P < 0.001.
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acts by increasing the concentration of Ca2+ and cAMP in the β-cell cytoplasm. Apart from the triggering role of 
Ca2+, insulin release is markedly amplified by cAMP, a second messenger required for normal insulin release43. In 
cardiac myocytes 1 nM BPA increases cAMP production44, therefore it is possible that glucose-induced increase 
in cAMP is amplified in β-cells after incubation with 1 nM BPA. Further research is necessary to mechanistically 
understand this effect.
The decrease in both the R-type Ca2+ currents and Cacna1e gene expression by 1 nM BPA implicated ERβ 
(Fig. 5). This is a BPA action triggered at low concentrations, similar to that found in human serum45 and far 
below concentrations used in classical toxicology9. For many years, it has been assumed that BPA behaved as a 
weak oestrogen. This was, in part, because in vitro experiments indicated that ERβ binds BPA with much lower 
affinity than the natural hormone, E2. The dissociation constant (Kd) for BPA upon binding to ERβ was approx-
imately 10–40 µM, and its binding induced transcriptional activity with a potency between 1000 and 5000-fold 
lower than E2, starting within the micromolar range46,47. These results, however, could not explain the in vivo 
data that indicated that BPA acted at concentrations within the nanomolar range48. During the past two decades, 
numerous studies have accumulated data describing the actions of BPA in vitro at concentrations of approx-
imately 1 nM10,19,20,49. The view of BPA as a weak oestrogen was based on the classical model in which either 
ERα or ERβ regulated gene transcription after binding to an oestrogen response element (ERE) in DNA and 
recruiting co-regulators50. Currently, our knowledge of oestrogen signalling has advanced, and it is accepted that 
both oestrogen receptors act through non-ERE-dependent pathways and activate signalling cascades outside of 
the nucleus37. It is through these pathways that BPA behaves as a potent oestrogen and triggers effects within the 
picomolar and nanomolar range32,51. Because the Cacna1e gene does not have an ERE sequence (result obtained 
Figure 6. Activation of oestrogen receptors α and β produces opposing actions on the Ca2+ currents in mouse 
pancreatic β-cells. (a) Average relationship between the Ca2+ current density and the voltage of the pulses 
in β-cells left untreated (Control; black squares, n = 14) or treated with 100 nM BPA (100 nM BPA; dark blue 
circles, n = 9) or 100 nM BPA plus 100 nM MPP (100 nM BPA + 100 nM MPP; green symbols, n = 18) for 
48 hours. (b) Histogram summarizing the average normalized peak Ca2+ current density shown in panel (a). 
(c) Average relationship between the Ca2+ current density and the voltage of the pulses in pancreatic β-cells 
(Control; black squares, n = 26) or treated with 100 nM (100 nM PPT; light red circles, n = 21) or 1000 nM PPT 
(100 nM PPT; dark red circles, n = 9) for 48 hours. (d) Histogram summarizing the average values of the peak 
Ca2+ current density in vehicle-treated β-cells (Control) or cells treated with 1 nM PPT (control, n = 20; 1 nM 
PPT, n = 16), 100 nM PPT (control, n = 26; 100 nM PPT, n = 21), or 1000 nM PPT (control, n = 14; 1000 nM 
PPT, n = 9), normalized to the peak density of the corresponding experimental control cells. The dotted line 
and arrows depict the monotonic dose-response relationship at the top of the histogram. Data are represented 
as the mean ± s.e.m. Student’s t-test: *P ≤ 0.05; **P < 0.01. (a) 100 nM BPA vs. 100 nM BPA + 100 nM MPP. (c) 
Control vs. 1000 nM PPT. (d) Paired comparison vs. control.
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Figure 7. Potentiation of the Ca2+ currents by BPA through oestrogen receptor α activation involves PI3K. 
(a) Relative Cav2.3 (Cacna1e) mRNA expression in control islets (black bar, n = 13) or islets exposed to 
100 nM PPT (light red bar, n = 11) or 1000 nM PPT (dark red bar, n = 11). Expression was normalized to the 
housekeeping gene HPRT. (b) Relative Cav2.3 (Cacna1e) mRNA expression in control islets (black bar, n = 7) 
or islets exposed to 100 nM BPA (dark blue bar, n = 7) or 100 nM BPA + 100 nM MPP (green bar, n = 7). (c) 
Average relationship between the Ca2+ current density and the voltage of the pulses in β-cells left untreated 
(Control; black squares, n = 26) or treated with 100 nM PPT (100 nM PPT; light red circles, n = 21) or 100 nM 
PPT + 100 nM wortmannin (100 nM PPT + Wort; magenta circles, n = 12). (d) Histogram summarizing the 
average normalized peak Ca2+ current density shown in panel (c). (e) Average relationship between the Ca2+ 
current density and the voltage of the pulses in β-cells left untreated (Control; black squares, n = 12) or treated 
with 100 nM BPA (100 nM BPA; dark blue circles, n = 15) or 100 nM BPA plus 100 nM wortmannin (100 nM 
BPA + Wort; magenta circles, n = 16). (f) Histogram summarizing the average normalized peak Ca2+ current 
density shown in panel (e). RNA samples used in (a) and (b) were obtained from the islets of 3–5 independent 
experiments. Data are represented as the mean ± s.e.m. Student’s t-test: *P ≤ 0.05; **P < 0.01. (b) Paired 
comparison with respect to control expression. (c) 100 nM PPT vs. 100 nM PPT + 100 nM wortmannin. (e) 
100 nM BPA vs. 100 nM BPA + 100 nM wortmannin.
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using Transfac52), its transcription must be downregulated by a non-ERE-dependent pathway. This can explain 
why BPA triggers transcriptional downregulation of Cacna1e at low dose such as 1 nM.
It is noteworthy that Cacan1e expression decreased within a whole range of BPA concentrations, from 1 nM to 
1 µM, but the Ca2+ currents were diminished only with 1 nM BPA. Therefore, another mechanism must account 
for the absence of the effect at 100 nM BPA. Because the Ca2+ currents were potentiated in ERβ−/− cells in the 
presence of BPA, we pursued the involvement of another oestrogen receptor in the non-monotonic response to 
BPA. Mouse pancreatic β-cells express ERα, ERβ and G protein-coupled oestrogen receptor 1 (GPER), and these 
receptors play roles in the regulation of insulin content, insulin secretion and β-cell survival53–58.
The present data suggest BPA doses of 100 nM and 1 µM potentiate Ca2+ currents by an ERα-dependent 
mechanism (Fig. 6). Evidence has indicated that ERα acts outside of the nucleus to activate PI3K to directly or 
indirectly enhance Ca2+ currents. ERα activates ERKs and PI3K in many cellular systems59,60 including β-cells19,38. 
PI3K also regulates Ca2+ channels in other excitable cells and promotes calcium channel trafficking to the plasma 
membrane61. Which Ca2+ channel types are regulated here by BPA is a subject for further research, but the whole 
Ca2+ current is enlarged in response to 100 nM BPA via ERα- and PI3K-mediated counteractions of the down-
regulation produced by ERβ (Fig. 7).
In summary, the results presented in this study provide a mechanistic explanation for the NMDR rela-
tionship between BPA exposure and Ca2+ entry. A model is proposed in Fig. 8. Low concentrations of BPA 
between 0.1–1 nM act via ERβ to transcriptionally downregulate Cav2.3 gene expression and are responsible 
for the decrease in the whole Ca2+ current measured in patch-clamp experiments and for the high extracellular 
K+-induced Ca2+ entry recorded in the Fura-2 experiments (Fig. 8b). The dynamic with higher BPA concen-
trations (100 nM-1 µM) involves both ERβ and ERα. ERβ at 100 nM BPA downregulates Cav2.3 gene expres-
sion and decreases the whole Ca2+ current, but ERα simultaneously potentiates whole Ca2+ currents through 
a PI3K-dependent pathway (Fig. 8c). Both effects counteract each other, and when Ca2+ currents or [Ca2+]i are 
measured as end points, there is no net effect of the high BPA concentrations. Therefore, we have demonstrated 
that this NMDR curve is the outcome of at least two different mechanisms activated by low and high doses of BPA 
involving ERβ and ERα.
It is important to note that NMDR can arise from different molecular mechanisms that are still greatly unchar-
acterized, but they are beginning to be uncovered. In the case of female cardiac myocytes, acute exposure to BPA 
(100 pM-1 µM) produced Ca2+ transients in an NMDR62,63, which was explained by a mechanism involving ERβ 
acting on two different end points, a potentiation of Ca2+ release and uptake from the sarcoplasmic reticulum and 
an inhibition of plasma membrane L-Type Ca2+ channels63.
The unveiling of NMDR molecular mechanisms should have a high impact in the field of toxicology because 
the NMDR mechanisms demonstrate that dose and effect do not move together in a predictable manner. It can-
not be always assumed that EDCs which are toxic at high doses are much less risky at lower, environmentally 
relevant levels. As a consequence, common concepts in regulatory toxicology such as the potency and threshold 
of effects cannot be easily applied in the case of BPA and, likely, other EDCs. Understanding the different mech-
anisms behind the NMDR should enable the development of new testing protocols to improve hazard and risk 
assessments.
Methods
Materials. Bisphenol-A was obtained from MP Biomedicals (Cat No 155118; Santa Ana, CA, USA). 
17β-oestradiol (Cat No E8875), diazoxide (Cat No D9530), and nifedipine (Cat No D7634) were obtained from 
Sigma-Aldrich (Saint Louis, MO, USA). SNX-482 (Cat No 4363) was obtained from PeptaNova (Sandhausen, 
Figure 8. Cellular Model of the NMDR relationship between BPA and Ca2+ entry. (a) Depolarization of the 
plasma membrane opens voltage-gated Ca2+ channles and induces Ca2+ influx (b) Low concentrations of BPA 
(100 pM-1 nM) decrease Cacna1e expression and Ca2+ entry in response to plasma membrane depolarization. 
(c) Higher BPA concentrations (100 nM-1 µM) activate ERα, which in turn enhances the Ca2+ currents in a 
PI3K-dependent manner. As the actions of ERβ on Cacna1e transcription remain during BPA exposure, the 
outcome is an unchanged Ca2+ entry.
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Germany). DPN (Cat No 1494), PPT (Cat No 1426), PHTPP (Cat No 2662), MPP dihydrochloride (Cat No 1991), 
PD98059 (Cat No 1213), and Wortmannin (Cat No 1232) were obtained from Tocris Cookson (Bristol, UK).
Experimental animals and protocols. Adult C57BL/6 J male mice (10–14 weeks old) were used. All ani-
mals were kept under standard housing conditions. ERβ−/− mice were generated as described previously64 and 
supplied by Jan-Ake Gustafsson’s laboratory. All genetically modified and wild-type animals were obtained from 
the same supplier and the same colony. All experimental procedures were performed according to the Spanish 
Royal Decree 1201/2005 and the European Community Council directive 2010/63/EU. The Ethics Committee 
from Universidad Miguel Hernández de Elche (Alicante, Spain) approved all methods used in this study (approv-
als ID: UMH-IB-AN-01–14 and UMH-IB-AN-02-14). Animals were treated humanely and with care to alleviate 
suffering. All procedures were carried out in accordance with the approved guidelines and regulations.
Culturing of islets and isolated islet cells. Pancreatic islets of Langerhans were isolated using collagenase 
(Sigma-Aldrich) as previously described65 and used according to the kind of experiment to be performed. The 
solution used for the isolation of the islets of Langerhans contained 115 mM NaCl, 5 mM KCl, 10 mM NaHCO3, 
1.1 mM MgCl2, 1.2 mM NaH2CO4, 2.5 mM CaCl2, 25 mM HEPES, 5 mM Glucose, and 0.25% BSA (pH 7.4). When 
required, pancreatic islets were dispersed into isolated cells and cultured in RPMI 1640 (Gibco, Thermo Fisher 
Scientific) containing 11 mM glucose and without phenol red at 37 °C in a humidified atmosphere of 95% O2 
and 5% CO2 for 48 hours. The medium was supplemented with 8% charcoal dextran-treated foetal bovine serum 
(HyClone, GE Health Care Life Sciences), 200 U/ml penicillin, 0.2 mg/ml streptomycin and 2 mM L-glutamine.
Fluorometric Ca2+ measurements. Intracellular Ca2+ measurements were performed in whole islets or 
single islet cells loaded with 5 μM Fura-2AM (Molecular Probes, Eugene, OR, USA) for at least 1 hour at room 
temperature or 30 min at 37 °C, respectively, in a humidified atmosphere of 95% O2 and 5% CO2. Recordings 
were made using a constant-volume chamber with a controlled solution exchange and conducted at 35–37 °C. 
The regular bath solution contained 120 mM NaCl, 5 mM KCl, 25 mM NaHCO3, 1.1 mM MgCl2, 2.5 mM CaCl2 
and 3 mM Glucose, pH 7.35 and was gassed with 95% O2 and 5% CO2. High extracellular K+ solutions, contain-
ing 20 mM or 65 mM KCl and 100 μM diazoxide, were used to elicit glucose-independent cell depolarization. 
Fluorescence measurements were obtained with an Axiovert 200 (Zeiss, Jana, Germany) inverted microscope. 
Images were acquired every 3 s with an extended high-resolution ORCA C4742-95 camera (Hamamatsu 
Photonics, Hamamatsu, Japan) using a dual-filter wheel (Sutter Instruments, Novato, CA, USA) equipped with 
340 and 380 nm, 10-nm bandpass filters (Omega Optical, Brattleboro, VT, USA). Data acquisition was performed 
with the Aquacosmos 2.6 software (Hamamatsu Photonics). Cytosolic Ca2+ changes are represented as the ratio 
of the fluorescence emission intensities at 360 and 380 nm (F360/F380; fluorescence arbitrary units). The results 
were plotted and analysed using commercially available software (Origin, OriginLab Corporation, Northampton, 
MA, USA).
Electrophysiology. A whole-cell patch-clamp configuration was used, except for the data in Fig. 1 in which 
the perforated patch whole-cell recording mode was applied. Pancreatic β-cells were identified by size (>5 pF) 
and the corresponding steady-state inactivation properties of the tetrodotoxin (TTX)-sensitive Na+ current66. 
Data were obtained using an Axopatch 200B patch-clamp amplifier (Axon Instruments Co. CA, USA). Patch 
pipettes were pulled from borosilicate capillaries (Sutter Instruments Co. CA, USA) using a flaming/brown 
micropipette puller P-97 (Sutter Instruments Co. CA, USA) and heat polished at the tip using an MF-830 micro-
forge (Narishige, Japan). The bath solution for the voltage-gated Ca2+ current recordings contained 118 mM 
NaCl, 20 mM TEA-Cl, 5.6 mM KCl, 2.6 mM CaCl2, 1.2 mM MgCl2, 5 mM HEPES and 5 mM glucose (pH 7.4 
with NaOH). The pipette solution for the voltage-gated Ca2+ current recordings consisted of 130 mM CsCl, 
1 mM CaCl2, 1 mM MgCl2, 10 mM EGTA, 3 mM MgATP and 10 mM HEPES (pH 7.2 with CsOH). After filling 
the pipette with the pipette solution, the pipette resistance was 3–5 MΩ. A tight seal (>1 GΩ) was established 
between the β-cell membrane and the tip of the pipette by gentle suction. The series resistance of the pipette usu-
ally increased to 6–15 MΩ after moving to whole-cell. Series resistance compensation was used (up to 70%) for 
keeping the voltage error below 5 mV during current flow. In the recordings of the electrical activity in Fig. 1, the 
bath solution contained 140 mM NaCl, 3.6 mM KCl, 1.5 mM CaCl2, 0.5 mM MgCl2, 10 mM HEPES and 0–11 mM 
glucose (pH 7.4 with NaOH). The pipette solution for the electrical activity recordings consisted of (in mM) 76 
K2SO4, 10 KCl, 10 NaCl, 1 MgCl2 and 5 HEPES (pH 7.35 with KOH). Amphotericin B (120–240 μg/ml; Sigma) 
was added to the pipette solution to perforate the patch67. The series resistance of the pipette usually increased to 
20–30 MΩ after amphotericin-B perforation. Potential values were not corrected for the liquid junction potential. 
Voltage-gated Ca2+ currents were compensated for capacitive transients and linear leak using a -P/4 protocol. The 
experiments designed to measure exocytosis were performed on isolated β-cells using the standard whole-cell 
configuration. Exocytosis was detected as the change in cell capacitance, which was measured by the ‘sine + DC’ 
method68. The Jclamp software connected to an Axopatch 200B amplifier was employed in these experiments 
using the single-sine feature. The amplitude of the sine wave was 20 mV, and the frequency was set to 1.5 kHz. 
Sinus segments were interrupted to apply 10 square voltage pulses (from −70 to 0 mV with 500-ms durations) at 
1 Hz to activate the voltage-gated Ca2+ entry that triggers exocytosis. In these experiments the bath solution was 
identical to the one used for the voltage-gated Ca2+ currents (see above) except that CaCl2 was increased to 5 mM. 
The pipette solution for the exocytosis measurements consisted of 140 mM CsCl, 10 mM NaCl, 1 mM MgCl2, 
0.05 mM EGTA, 3 mM MgATP, 0.1 mM cAMP and 5 mM HEPES (pH 7.2 with CsOH). Pipettes in exocytosis 
experiments were coated with Sylgard 184 (Dow Corning Europe, Belgium) rubber to decrease the pipette capac-
itive transients. Data were filtered (2 kHz) and digitized (10 kHz) using a Digidata 1322 A (Axon Instruments 
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Co. CA, USA) and stored in a computer for subsequent analysis using commercial software (pClamp9, Axon 
Instruments Co. CA, USA). All experiments were carried out at 32–34 °C.
Insulin secretion and content. For the insulin secretion measurements, the 48 hours-cultured islets in the 
presence of vehicle or BPA (1 nM) were washed and kept in an incubator at 37 °C for 2 hours with a buffer solution 
containing 140 mM NaCl, 4.5 mM KCl, 2.5 mM CaCl2, 1 mM MgCl2, 20 mM HEPES, 3 mM D-glucose with a final 
pH of 7.4. Groups of 5 islets were then incubated in 400 μl of this buffer in the presence of 3, 8, or 16 mM glucose 
or 65 mM K+ in 3 mM glucose for 1 hour in the incubator at 37 °C. Afterwards, 100 μl of the buffer solution with 
the corresponding glucose concentration and 5% BSA was added, incubated at room temperature for 3 min and 
left to cool for 15 min on ice. Then, the medium was collected, and insulin was measured in duplicate samples 
using the Mouse Insulin ELISA Kit (Mercodia, Sweden). For the insulin content measurement, the islets grouped 
in batches of 5 were handpicked with a micropipette and incubated overnight in an ethanol/HCl buffer (75% 
Ethanol (v/v); 0.4% HCl (stock 37%) (v/v) and 24.6% distilled water (v/v)) at 4 °C. At the end of the incubation 
period, the buffer was removed and examined for insulin content using the Mouse Insulin ELISA Kit (Mercodia, 
Sweden)). Protein determination was performed using the Bradford dye method69. The insulin and protein con-
tents were determined in each islet sample, and the ratio of both parameters was calculated for each sample.
Real-time PCR. Pancreatic islets were isolated by collagenase digestion as described above and incubated 
in groups in RPMI 1640 in the presence of the stimuli for 48 hours. Quantitative PCR assays were performed 
using the CFX96 Real Time System (Bio-Rad, Hercules, CA, USA). Groups of 200–250 isolated islets were used 
for RNA extraction. RNA was extracted using a commercial kit (RNeasy Micro kit, Qiagen) according to the 
manufacturer’s instructions. RNA (0.5 μg) was reverse-transcribed using the High Capacity cDNA Reverse 
Transcription kit (Applied Biosystems, Foster City, CA, USA). Amplification reactions were carried out in 
medium containing 200 nM of each primer, 1 μl cDNA, and 1x IQ SYBR Green Supermix (Bio-Rad). HPRT was 
used as the housekeeping gene for the semiquantitative RT-PCR. PCR primers were as follows: Cacna1e forward, 
5′-CCGATGATGATGAGAGGGAT-3′; Cacna1e reverse, 5′-TGCTGACTGTCTTCCAATGC-3′; Cacna1c for-
ward, 5′-GAGCCACGGTGAATCAGGA-3′; Cacna1c reverse, 5′-GCAGTACTCGGCTTCTTCACTCA-3′; Hprt1 
forward, 5′-GGTTAAGCAGTACAGCCCCA-3′; Hprt1 reverse, 5′-TCCAACACTTCGAGAGGTCC-3′. Samples 
were subjected to the following conditions: 3 minutes at 95 °C, 40 cycles (5 seconds at 95 °C, 5 seconds at 60 °C, 
and 10 seconds at 72 °C), and a melting curve of 65–95 °C. The resulting values were analysed with CFX Manager 
Version 1.6 (Bio-Rad) and were expressed as the relative expression with respect to the control values (2−ΔΔCT)70.
Statistical analysis. The GraphPad Prism 5.0 software (GraphPad Software, Inc., CA, USA) was used for 
all statistical analyses. Data are expressed as the mean ± SEM. To assess differences between exposure groups, 
we used Student’s t-test or one-way analysis of variance (ANOVA) when appropriate. When data did not pass 
the parametric test, we used the Mann-Whitney and Kruskal-Wallis ANOVA tests (followed by Dunn’s test), 
depending on the experimental groups involved in the comparison. A probability level of ≤0.05 was considered 
statistically significant.
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